Exchange: NYSE
Industry: Food & Drug Retailers
Last Trade: 4:01 PM ET 5/17/2013
Last 10 Quotes:
What's This?
| Fiscal Q4 Ending 02/13 |
Fiscal Q3 Ending 11/12 |
Fiscal Q2 Ending 08/12 |
Fiscal Q1 Ending 05/12 |
Fiscal Q4 Ending 02/12 |
|
Sales/Revenue |
6,455,245 | 6,237,847 | 6,230,884 | 6,468,287 | 7,146,754 |
Cost of Goods Sold (COGS) incl. D&A |
4,407,482 | 4,426,526 | 4,520,463 | 4,719,516 | 5,364,679 |
COGS excluding D&A |
4,304,531 | 4,323,736 | 4,418,464 | 4,613,145 | 5,257,478 |
Depreciation & Amortization Expense |
102,951 | 102,790 | 101,999 | 106,371 | 107,201 |
Gross Income |
2,047,763 | 1,811,321 | 1,710,421 | 1,748,771 | 1,782,075 |
SG&A Expense |
1,682,332 | 1,612,198 | 1,618,169 | 1,688,066 | 1,758,325 |
Research & Development |
NA | 0 | 0 | 0 | 0 |
Other SG&A |
1,682,332 | 1,612,198 | 1,618,169 | 1,688,066 | 1,758,325 |
Other Operating Expense |
0 | 0 | 0 | 0 | 0 |
Unusual Expense |
159,227 | 14,366 | 7,783 | 29,985 | 72,371 |
Non Operating Income/Expense |
-2,491 | 6,262 | 2,954 | 10,051 | 966 |
Equity in Affiliates (Pretax) |
NA | 0 | 0 | 0 | 0 |
Interest Expense |
127,408 | 128,371 | 129,054 | 130,588 | 137,739 |
Gross Interest Expense |
127,408 | 128,371 | 129,054 | 130,588 | 137,814 |
Pretax Income |
76,305 | 62,648 | -41,631 | -89,817 | -185,469 |
Income Tax |
-46,782 | 777 | -2,866 | -61,729 | -24,219 |
Equity in Affiliates |
0 | 0 | 0 | 0 | 0 |
Consolidated Net Income |
123,087 | 63,179 | -38,791 | -28,088 | -161,250 |
Minority Interest Expense |
0 | 0 | 0 | 0 | 0 |
Net Income |
123,087 | 63,179 | -38,791 | -28,088 | -161,250 |
Extraordinaries & Discontinued Operations |
0 | 0 | 0 | 0 | 0 |
Extra Items & Gain/Loss Sale Of Assets |
0 | 0 | 0 | 0 | 0 |
Cumulative Effect - Accounting Chg |
0 | 0 | 0 | 0 | 0 |
Discontinued Operations |
0 | 0 | 0 | NA | 0 |
Net Income After Extraordinaries |
123,087 | 63,179 | -38,791 | -28,088 | -161,250 |
Preferred Dividends |
2,716 | 2,651 | 2,612 | 2,599 | 2,560 |
Net Income available to Common |
120,371 | 60,528 | -41,403 | -30,687 | -163,810 |
Operational EPS |
0.26 | 0.08 | -0.04 | -0.01 | -0.13 |
EPS (basic) |
0.14 | 0.07 | -0.05 | -0.03 | -0.18 |
EBITDA |
468,382 | 301,913 | 194,251 | 167,076 | 130,951 |
Depreciation & Amortization Expense |
102,951 | 102,790 | 101,999 | 106,371 | 107,201 |
Common Shares Outstanding |
907,259 | 917,808 | 889,645 | 887,516 | 885,819 |
Basic Shares Outstanding |
889,562 | 891,031 | 889,645 | 887,516 | 885,819 |
Diluted Shares Outstanding |
907,259 | 917,808 | 889,645 | 887,516 | 885,819 |
Diluted EPS after Extraordinary Items |
0.13 | 0.07 | -0.05 | -0.03 | -0.18 |
Discont. Operations Per Share |
0 | 0 | 0 | 0 | 0 |
Continued operations EPS |
0.14 | 0.07 | -0.04 | -0.03 | -0.18 |
*Figures in thousands of U.S. Dollars except shares outstanding.
